UNA Platform Technology definition

UNA Platform Technology means the technology for the development, production and use of UNAs and compounds containing one or more UNAs, including, without limitation, Know-How relating to the manufacture, formulation, ingredients, preparation, presentation, means of delivery, dosage or packaging of such UNAs, all as in existence as of the Effective Date.
Sample 1Sample 2Sample 3
UNA Platform Technology means the technology for the development, production and use of UNAs and compounds containing one or more UNAs, including, without limitation, Know-How relating to the manufacture, formulation, ingredients, preparation, presentation, means of delivery, dosage or packaging of such UNAs, all as in existence as of the Effective Date. [**] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1

Examples of UNA Platform Technology in a sentence

  • For purposes of clarity, such [***] license shall not include any rights to the UNA Platform Technology IP.

  • If DEBIOPHARM decides to finally abandon or not to maintain any such patent application or patent within the DEBIOPHARM Patents that are specifically related to the Formulation Technology IP and UNA Platform Technology IP, DEBIOPHARM shall provide COMPANY with [***] days’ prior written notice of such determination (or, at DEBIOPHARM’s sole discretion, such other period of time reasonably necessary to allow COMPANY to assume such responsibilities).

  • DEBIOPHARM hereby grants to COMPANY a [***] license, with the right to grant sublicenses, under Intellectual Property created by DEBIOPHARM during the performance of the Joint Research Plan directly relating to the COMPANY Formulation Technology IP and UNA Platform Technology IP.

  • In the event that DEBIOPHARM develops such IP on COMPANY Formulation Technology IP and/or UNA Platform Technology IP, DEBIOPHARM shall promptly notify COMPANY and provide COMPANY any information and documents necessary for COMPANY to understand and use DEBIOPHARM IP directly relating to the COMPANY Formulation Technology IP and UNA Platform Technology IP.

  • In such event, COMPANY shall have the right, at its option, to control the filing, prosecution and/or maintenance of any such DEBIOPHARM Patents and patent applications specifically related to the Formulation Technology IP and UNA Platform Technology IP at its own expense in the name of DEBIOPHARM.

  • DEBIOPHARM shall, or shall instruct patent counsel, to keep COMPANY regularly informed of the progress of the prosecution, issuance and maintenance of all patent applications and patents within the DEBIOPHARM Patents that are specifically related to the Formulation Technology IP and UNA Platform Technology IP, and shall be available to discuss any issues and answer any questions COMPANY may have and take reasonable comments made by COMPANY into consideration.

  • COMPANY will not finally abandon any patent application or patent rights included in the Formulation Technology IP and UNA Platform Technology IP without first notifying DEBIOPHARM in writing; should DEBIOPHARM fail to respond in writing within [***] days of such notice, DEBIOPHARM shall be deemed to have given its approval to COMPANY’s course of action.

  • For clarity, COMPANY has the right to publish on Formulation Technology IP and UNA Platform Technology IP if such publication does not use or reference any Data, Joint IP or Inventions that arise under the Joint Research Plan; and further, COMPANY has the right to publish on COMPANY UsiRNA Technology if such publication is outside of the Exclusive Field and does not use or reference any Data, Joint IP or Inventions that arise under the Joint Research Plan.

Related to UNA Platform Technology

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Know-How means techniques, technology, trade secrets, inventions (whether patentable or not), methods, know-how, data and results (including pharmacological, toxicological and clinical data and results), analytical and quality control data and results, regulatory documents, and other information, compositions of matter, cells, cell lines, assays, animal models and other physical, biological, or chemical material.